MedTrace Logo

Improving Access to Abortion in the Republic of Georgia

NCT04458558 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-07-07

No results posted yet for this study

Summary

In the Republic of Georgia, the medical abortion regimen involves three in-person visits. This study aims to pilot and evaluate a simplified medical abortion service delivery model that will reduce the number of in-person visits to only one visit for diagnosis and counseling. Medication will be mailed along with two multi-level pregnancy tests to study participants, who will assess their abortion outcome at home.

Conditions

  • Abortion Early
  • Pregnancy Related

Interventions

DRUG

Mifepristone

Participants will receive mifepristone at a preferred address by mail rather than standard care at clinic visit.

Sponsors & Collaborators

  • Gynuity Health Projects

    collaborator OTHER

  • Healthy Life

    collaborator UNKNOWN

  • Grand Challenges Canada

    collaborator OTHER

  • Center for Information and Counseling on Reproductive Health - Tanadgoma

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Georgia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458558 on ClinicalTrials.gov